ATHE fundamentals
An in-depth look to Alterity Therapeutics Limited operating, investing, and financing activities
ATHE free cash flow for H1 25 is -5.53 M USD. For 2024, ATHE free cash flow was -8.26 M USD and operating cash flow was -8.26 M USD.
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM